KRAS and neoplasm: DETECTR can be adapted to detect various cancer-related mutations, such as those in oncogenes (e.g., KRAS, BRAF) or tumor suppressor genes (e.g., TP53), after detecting circulating tumor DNA (ctDNA) in blood samples.